Matthew Brams
Fondateur chez CINGULATE INC.
Fortune : 27 310 $ au 30/04/2024
Postes actifs de Matthew Brams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CINGULATE INC. | Directeur Technique/Scientifique/R&D | 01/01/2013 | - |
| Fondateur | 01/01/2013 | - | |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Directeur/Membre du Conseil | - | - |
| Directeur Technique/Scientifique/R&D | 01/01/2014 | - | |
| Fondateur | - | - | |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Directeur Technique/Scientifique/R&D | 01/01/2013 | - |
| Fondateur | 01/01/2013 | - | |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Historique de carrière de Matthew Brams
Anciens postes connus de Matthew Brams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Bayou City Research, Inc. | Directeur Technique/Scientifique/R&D | 01/04/1999 | 01/01/2021 |
Formation de Matthew Brams
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Health Science Center at Houston | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Bayou City Research, Inc. |
- Bourse
- Insiders
- Matthew Brams
- Expérience
